Ads
related to: CEL
Search results
Europe approves new multiple myeloma therapy CARVYKTI
Investing.com· 5 days agoThe European Commission has granted approval to CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) for...
FDA requests more info for Abeona pz-cel market application (NASDAQ:ABEO)
Seeking Alpha· 4 days agoThe FDA has declined to approve Abeona Therapeutics' (ABEO) therapy pz-cel, stating that it needs...
FDA Seeks More Information About RDEB Rx Under Review
Medscape· 2 days agoPz-cel, which comprises autologous, COL7A1 gene–corrected epidermal sheets, was designed to enable normal type VII collagen expression and facilitate wound healing and pain reduction in RDEB wounds.
Gilead Sciences Inc (GILD) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...
GuruFocus.com via Yahoo Finance· 13 hours agoQ: How are the recent ODAC meetings regarding CAR-T therapies and MRD as an endpoint affecting Gilead's strategies, especially for anito-cel in multiple myeloma? A: Cindy ...
Abeona shares tumble as FDA declines to approve skin disorder treatment
Reuters via Yahoo News· 4 days agoThe health regulator sought certain additional data to satisfy requirements pertaining to chemistry,...
Call of Duty Modern Warfare III Season 3 Reloaded Includes Some Crazy Skins And A Lot Of Fun -...
Gameranx· 1 day agoCall of Duty Modern Warfare III Season 3 Reloaded includes a new gun, new modes, new powerups, and...
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
WSYR 9 Syracuse· 1 day agoFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against bluebird bio, Inc. ("Blue" or the "Company") (NASDAQ: BLUE) and reminds investors of the ...
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses...
WJET - WFXP Erie· 4 days agoThe Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class...
Gene Therapy Trial for Sickle Cell Disease Publishes Final Results
Technology Networks· 20 hours agoIn a landmark study, an international consortium led by researchers at Children’s Hospital of...
FDA rejects Abeona cell therapy, asks for more manufacturing data
BioPharma Dive via Yahoo Finance· 3 days agoAbeona on Monday said the FDA issued a so-called complete response letter for the therapy, known as...
